[EN] ARYL GLYCINAMIDE DERIVATIVES AND THEIR USE AS NK1 ANTAGONISTS AND SEROTONIN REUPTAKE INHIBITHORS<br/>[FR] DERIVES D'ARYLE GLYCINAMIDE ET UTILISATION EN TANT QU'ANTAGONISTES DE NK1 ET EN TANT QU'INHIBITEURS DU RECAPTAGE DE SEROTONINE
申请人:ASTRAZENECA AB
公开号:WO2005100325A1
公开(公告)日:2005-10-27
Compounds of the following Formula (I) wherein R1 and R2 are independently selected from alkyl or alkenyl or from a heterocyclic ring together with the N to which they are bound, n is 0-2, Ar1 is (substituted) phenyl and Ar1 is (substituted) phenyl, naphthyl or tetralin, further as defined in the specification, in vivo-hydrolysable precursors and pharmaceutically acceptable salts thereof, the use in therapy and pharmaceutical compositions and methods of treatment using the same. The compounds are neurokinin 1 (NK1) receptor antagonists and/or serotonin reuptake inhibitors, with medical indications for depression, anxiety disorders and other conditions.
以下式(I)的化合物,其中R1和R2独立地选自烷基或烯基或杂环环以及它们所结合的N,n为0-2,Ar1为(取代)苯基,Ar1为(取代)苯基,萘基或四氢萘,进一步在说明书中定义,活体内可水解的前体和药用可接受的盐,用于治疗和药物组合物以及使用相同的方法。该化合物是神经激肽1(NK1)受体拮抗剂和/或5-羟色胺再摄取抑制剂,用于治疗抑郁症、焦虑症和其他疾病。